Drawing for RETINA

USPTO serial 78258868

RETINA

Reviewed by CopyMark Law Group

Reg. 3072721Status 710
Filing date
Status date
Registration date
Mar 28, 2006
Examiner
PHAM, LANA H
Law office
PUBLICATION AND ISSUE SECTION

What this means

Status 710 means the registration was cancelled because a required Section 8 declaration of continued use was not filed within the deadline (including any grace period). The federal registration is no longer active. Evaluate filing a new application if you still use the mark, or petition if cancellation was erroneous. Consult counsel on remaining common-law rights.

Status 710: Status 710 means the registration was cancelled because a required Section 8 declaration of continued use was not filed within the deadline (including any grace period). The federal registration is no longer active.

Need help with RETINA?

If you own this trademark, we can monitor new filings and help with USPTO deadlines. If you do not, we can file a new U.S. application.

Current trademark owner
Monitor this mark, or talk with CopyMark about this registration.
Not the owner?
File a new U.S. trademark application, or speak with our attorneys.

Owner

Attorney of record

The USPTO lists this attorney as the applicant's representative for correspondence on this application.

Michael B. Lasky

Michael B. Lasky Altera Law Group220 South Sixth Street1700 US Bank Plaza SouthMinneapolis, MN 55402

Goods and services

ClassDescriptionStatusFirst use
001Diagnostic preparations and reagents for scientific or research use; chemical and biochemical reagents for scientific RNA and DNA research use; kits for DNA and RNA analysis comprised primarily of chemical reagents for scientific or research use, all specifically in the field of HIV and other virus detection, mitochondrical function and/or toxicity and for tumor markersSECTION 8 - CANCELLED—
005Diagnostic reagents for in vitro use in biochemistry, clinical chemistry and microbiology, namely molecular diagnostic kits used to generate a clinical or scientific result by amplification and / or detection of DNA or RNA sequences in tissues, body fluids and/or cells of human or animal origin, specifically in the field of HIV and other virus detection, mitochondrical function and / or toxicity, and for tumor markers; medical diagnostic reagents; kits for DNA and RNA analysis comprised primarily of chemical reagents for clinical or medical laboratory use, all specifically in the field of HIV and other virus detection, mitochondrical function and/or toxicity and for tumor markersSECTION 8 - CANCELLED—
010Medical and veterinary diagnostic apparatus and instruments to be used with molecular diagnostic kits used to generate a clinical or scientific result by amplification and/or detection of DNA or RNA sequences in tissues, body fluids and / or cells of human or animal origin, specifically in the field of HIV and other virus detection, mitochondrical function and / or toxicity, and for tumor markersSECTION 8 - CANCELLED—

Related trademarks

CopyMark links this record to cited §2(d) serials, the owner's other marks, Nice classes, similar mark names, and recently changed USPTO applications.

Prosecution history

DateCodeEventWhat it means
Nov 2, 2012C8..CANCELLED SEC. 8 (6-YR)—
Mar 5, 2008TCCATEAS CHANGE OF CORRESPONDENCE RECEIVED—
Mar 28, 2006R.PRREGISTERED-PRINCIPAL REGISTERYour trademark is registered on the Principal Register — the strongest form of federal trademark protection. You may use the ® symbol for the covered goods and services. Maintenance filings (Section 8 and renewals) are required to keep the registration alive.
Feb 14, 2006DOCKASSIGNED TO EXAMINER—
Jan 3, 2006PUBOPUBLISHED FOR OPPOSITIONYour mark was published in the USPTO Official Gazette for a 30-day opposition window. During that period, third parties who believe they would be harmed can file an opposition. If no opposition is filed, prosecution usually continues toward registration or a Notice of Allowance.
Dec 14, 2005NPUBNOTICE OF PUBLICATION—
Nov 15, 2005PREVLAW OFFICE PUBLICATION REVIEW COMPLETED—
Nov 4, 2005ALIEASSIGNED TO LIE—
Oct 31, 2005CNSAAPPROVED FOR PUB - PRINCIPAL REGISTER—
Aug 4, 2005ACECAMENDMENT FROM APPLICANT ENTERED—
Mar 10, 2005CRFACORRESPONDENCE RECEIVED IN LAW OFFICE—
Mar 10, 2005MAILPAPER RECEIVED—
Jan 14, 2005GNRTNON-FINAL ACTION E-MAILEDA non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application.
Jan 14, 2005CNRTNON-FINAL ACTION WRITTENA non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application.
Jan 4, 2005TEMETEAS/EMAIL CORRESPONDENCE ENTERED—
Dec 20, 2004CRFACORRESPONDENCE RECEIVED IN LAW OFFICE—
Dec 20, 2004TROATEAS RESPONSE TO OFFICE ACTION RECEIVEDThis event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action.
Jul 1, 2004GNFRFINAL REFUSAL E-MAILEDA final Office Action (final refusal) means the examining attorney is maintaining at least one refusal and your options are narrower. You can file a response addressing the refusal, appeal to the Trademark Trial and Appeal Board, or let the application abandon.
May 21, 20041.BDSec. 1(B) CLAIM DELETED—
May 21, 2004CRFACORRESPONDENCE RECEIVED IN LAW OFFICE—
May 21, 2004MAILPAPER RECEIVED—
Nov 21, 2003GNRTNON-FINAL ACTION E-MAILEDA non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application.
Nov 20, 2003DOCKASSIGNED TO EXAMINER—

Frequently asked questions

Related guidance